| 发明名称 |
SNS-595 UND ANWENDUNGSVERFAHREN |
| 摘要 |
The present invention relates to a compound which is (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in treating a hematologic cancer, wherein the compound is prepared to be administered in a dose of 60 mg/m 2 - 110 mg/m 2 . |
| 申请公布号 |
AT451924(T) |
申请公布日期 |
2010.01.15 |
| 申请号 |
AT20050732554T |
申请日期 |
2005.03.14 |
| 申请人 |
SUNESIS PHARMACEUTICALS, INC. |
发明人 |
ARKIN, MICHELLE;HYDE, JENNIFER;WALKER, DUNCAN;WRIGHT, JASMINE |
| 分类号 |
A61K31/44;A61K31/4745 |
主分类号 |
A61K31/44 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
